Long-term antibody response following COVID-19 vaccination in patients receiving peritoneal dialysis
Semin Dial
.
2022 Nov;35(6):559-560.
doi: 10.1111/sdi.13079.
Epub 2022 Mar 29.
Authors
Rajkumar Chinnadurai
1
2
,
Chittesh Ramgobin
1
,
Henry H L Wu
2
3
,
Emma Hayes
1
,
Joanne Collier
1
,
David Lewis
1
,
Dimitrios Poulikakos
1
2
Affiliations
1
Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance Foundation Trust, Salford, UK.
2
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
3
Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
PMID:
35348245
PMCID:
PMC9115424
DOI:
10.1111/sdi.13079
No abstract available
Publication types
Letter
MeSH terms
Antibody Formation
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Peritoneal Dialysis*
Renal Dialysis
Vaccination
Substances
COVID-19 Vaccines